FCGRT and cancer: SPEDOX-6 remarkably suppresses HT-1080 (fibrosarcoma cell line STS model but recently reclassified as dedifferentiated chondrosarcoma due to characteristic IDH1 mutation, with the lowest FcRn expression level among cancer cell lines), with 3 out of 10 mice attaining tumor-free status.